Avoiding biohazards in medical, veterinary and research laboratories

Biotechnic and Histochemistry

Volumn 76, Issue 4, 2001, Pages 183-206

  Grizzle, W E ^a   Fredenburgh, J ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Biohazards; Creutzfeldt Jakob; Hepatitis; HIV; Safety; Universal precautions

Indexed keywords

ACCREDITATION; ARTICLE; CLINICAL LABORATORY; FATALITY; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; LABORATORY PERSONNEL; MEDICAL RESEARCH; MICROBIOLOGY; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; OCCUPATIONAL SAFETY; PATHOGENICITY; RISK ASSESSMENT; SYMPTOMATOLOGY; UNITED STATES; VETERINARY MEDICINE; WORK ENVIRONMENT;

ANIMALIA; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0035190122     PISSN: 10520295     EISSN: None     Source Type: Journal    
DOI: 10.1080/bih.76.4.183.206     Document Type: Article

References (75)

1. Contracting occupationally related psittacosis
2. Mycobacteria. General culture methodology and safety considerations
3. Recovery of infectious human immunodeficiency virus from cells treated with 1% paraformaldehyde
4. Protection of workers from infectious disease transmitted by blood and tissues
5. Recommendations for prevention of HIV transmission in health care settings
6. Recommendations for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health care settings
7. Guidelines for prevention of transmission of human immunodeficiency virus and hepatitis B virus to health-care and public safety workers
8. Laboratory management of agents associated with Hantavirus pulmonary syndrome: Interim biosafety guidelines
9. Case-control study of HIV serconversion in health-care workers after percutaneous exposure to HIV-infected blood France, United Kingdom, and United States, January 1998-August 1994
10. Use of bleach in prevention of transmission of HIV in health care settings
11. Guidelines for the safe transport of infectious substances and diagnostic specimens
12. + T cell determinations in persons infected with human immunodeficiency virus (HIV)
13. Safer needle devices: Protecting health care workers
14. NIOSH Alert: Preventing allergic reactions to natural rubber latex in the workplace
15. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention
16. Laboratory risk assessment: What, why, and how. Risk assessment in the infectious disease laboratory
17. DHHS (NIOSH): Selecting, evaluating, and using sharps disposal containers
18. Potential for allergy to natural rubber latex gloves and other natural rubber products
19. Preventing needlestick injuries in health care settings. NIOSH Alert
20. Guidelines for surveillance, prevention, and control of West Nile virus infection United States
21. Exposure to blood
22. Compendium of measures to control Chlamydia psittaci infection among humans (psittacosis) and pet birds (avian chlamydiosis), 2000. Centers for Disease Control and Prevention
23. Bovine sera used in the manufacture of biologicals: Current concerns and policies of the US Food and Drug Administration regarding the transmissible spongiform encephalopathies
24. Transmissible spongiform encephalopathies in humans
25. Long lasting viability of HIV after patient's death
26. Survival of hepatitis B virus after drying and storage for one week
27. BSE: The final resting place
28. Creutzfeldt-Jakob disease: Management of accidental contamination of neurosurgical instruments, pathology equipment, and solutions
29. Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: Implications for screening of blood and tissue donors
30. Variant Creutzfeldt-Jakob disease
31. Effects of cellular fixatives on human immunodeficiency virus production
32. Behavioral-Diagnostic analysis of compliance with universal precautions among nurses
33. Global burden of tuberculosis: Estimated incidence, prevalence, and mortality by country
34. The return of tuberculosis
35. The AIDS epidemic considerations for the 21st century
36. Accidental blood contact during orthopedic surgical procedures
37. HIV-1 detection by nested PCR and viral culture in fresh or cryopreserved postmortem skin: Potential implications for skin handling and allografting
38. Viability of mycobacteria in formalin-fixed tissues
39. Biological and chemical hazards of forensic skeletal analysis
40. Heat treatment of whole blood and serum before chemical analysis
41. Guidelines to avoid personnel contamination by infective agents in research laboratories that use human tissues
42. Reflections on the transmissible spongiform encephalopathies
43. Hepatitis E virus an update
44. Bovine spongiform encephalopathy: Current status and possible impacts
45. Medical progress: Creutzfeldt-Jakob disease and related spongiform encephalopathies
46. Recent developments in the epidemiology of virus diseases and BSE
47. Stability of human immunodeficiency virus (HIV) antibodies in postmortem samples
48. Guidelines for the shipment of dried blood spot specimens
49. Risk of transmission of blood-borne viral infection in orthopaedic and trauma surgery
50. Powder-free protein-poor natural rubber latex gloves and latex sensitization
51. Pathogenesis, natural history, treatment, and prevention of hepatitis C
52. HIV and the necroscopy
53. Cleaning CJD-contaminated instruments
54. Sectioning fresh human bone: The reduction of aerosol and physical hazards
55. Thermal inactivation of the acquired immunodeficiency syndrome virus III/lymphadenopathy-associated virus, with special reference to antihemophilic factor
56. The hazard of infectious agents in microbiologic laboratories
57. Isolation of human immunodeficiency virus (HIV) at autopsy one to six days postmortem
58. Surveillance for Lyme Disease - United States, 1992-1998
59. HIV and hepatotropic viruses: Interactions and treatments
60. Epidemic hepatitis in a clinical laboratory: Possible association with computer handling
61. Biosafety considerations in handling medically important fungi
62. Stability and inactivation of HTLV-III/LAV under clinical and laboratory environments
63. Protection of personnel and environment against Creutzfeldt-Jakob disease in pathology laboratories
64. Biosafety in the clinical mycobacteriology laboratory
65. Transfusion-associated human immunodeficiency virus type 1 from screened antibody-negative blood donors
66. Biosafety guidelines for sorting of unfixed cells
67. Biosafety guidelines for flow cytometric analysis of human immunodeficiency virus-infected samples
68. Inactivation of lymphadenopathy-associated virus by heat, gamma rays, and ultraviolet light
69. Aerosol production associated with clinical laboratory procedures
70. Best practice No. 158, neuropathology
71. Animal allergens in the workplace